HK1023995A1 - Synthesis of acridine derivative multidrug-resistant inhibitors - Google Patents

Synthesis of acridine derivative multidrug-resistant inhibitors

Info

Publication number
HK1023995A1
HK1023995A1 HK00103130A HK00103130A HK1023995A1 HK 1023995 A1 HK1023995 A1 HK 1023995A1 HK 00103130 A HK00103130 A HK 00103130A HK 00103130 A HK00103130 A HK 00103130A HK 1023995 A1 HK1023995 A1 HK 1023995A1
Authority
HK
Hong Kong
Prior art keywords
synthesis
multidrug
acridine derivative
formula
resistant inhibitors
Prior art date
Application number
HK00103130A
Other languages
English (en)
Inventor
Matthew Jude Sharp
Catherine J Mader
Calum Strachan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1023995A1 publication Critical patent/HK1023995A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK00103130A 1997-05-23 2000-05-25 Synthesis of acridine derivative multidrug-resistant inhibitors HK1023995A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710612.4A GB9710612D0 (en) 1997-05-23 1997-05-23 Synthesis of acridine derivatives
PCT/EP1998/002991 WO1998052923A1 (en) 1997-05-23 1998-05-22 Synthesis of acridine derivative multidrug-resistant inhibitors

Publications (1)

Publication Number Publication Date
HK1023995A1 true HK1023995A1 (en) 2000-09-29

Family

ID=10812906

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103130A HK1023995A1 (en) 1997-05-23 2000-05-25 Synthesis of acridine derivative multidrug-resistant inhibitors

Country Status (19)

Country Link
US (1) US6248891B1 (de)
EP (1) EP0983246B1 (de)
JP (1) JP4390861B2 (de)
KR (1) KR100536155B1 (de)
CN (1) CN1178918C (de)
AT (1) ATE228506T1 (de)
AU (1) AU744402B2 (de)
BR (1) BR9809143A (de)
CA (1) CA2289492C (de)
DE (1) DE69809733T2 (de)
DK (1) DK0983246T3 (de)
ES (1) ES2187984T3 (de)
GB (1) GB9710612D0 (de)
HK (1) HK1023995A1 (de)
HU (1) HUP0002083A3 (de)
IL (1) IL132593A (de)
PL (1) PL190109B1 (de)
PT (1) PT983246E (de)
WO (1) WO1998052923A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
MA26696A1 (fr) 1998-10-08 2004-12-20 Smithkline Beecham Plc Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DK1189637T3 (da) * 1999-05-17 2006-12-11 Cancer Res Ventures Ltd Produkter til forbedring af biotilgængeligheden for oralt indgivne medikamenter
SI21507A (sl) 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
US7829578B1 (en) 2005-12-12 2010-11-09 Oregon Health & Science University Aromatic ketones and uses thereof
WO2008064011A1 (en) 2006-11-13 2008-05-29 The Government Of The U.S. Of America As Represented By The Department Of Veterans Affairs Acridone compounds
US8598354B2 (en) 2008-12-05 2013-12-03 University Of South Florida Compounds having antiparasitic or anti-infectious activity
IL277335B2 (en) * 2018-03-21 2024-03-01 Izumi Tech Llc Analogues of alcridar with deuterium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2783680B2 (ja) * 1991-01-11 1998-08-06 ラボラトワール、グラクソ、ソシエテ、アノニム アクリジン誘導体
CZ104197A3 (en) * 1994-10-05 1997-09-17 Glaxo Wellcome Inc Pharmaceutical preparation

Also Published As

Publication number Publication date
EP0983246A1 (de) 2000-03-08
KR100536155B1 (ko) 2005-12-14
CA2289492C (en) 2009-03-24
JP2002502371A (ja) 2002-01-22
JP4390861B2 (ja) 2009-12-24
BR9809143A (pt) 2000-08-01
US6248891B1 (en) 2001-06-19
PT983246E (pt) 2003-04-30
AU744402B2 (en) 2002-02-21
KR20010012817A (ko) 2001-02-26
DE69809733D1 (de) 2003-01-09
HUP0002083A3 (en) 2002-03-28
ES2187984T3 (es) 2003-06-16
IL132593A (en) 2004-07-25
CN1255918A (zh) 2000-06-07
PL190109B1 (pl) 2005-10-31
IL132593A0 (en) 2001-03-19
HUP0002083A2 (hu) 2001-04-28
CN1178918C (zh) 2004-12-08
CA2289492A1 (en) 1998-11-26
GB9710612D0 (en) 1997-07-16
DE69809733T2 (de) 2003-09-18
EP0983246B1 (de) 2002-11-27
ATE228506T1 (de) 2002-12-15
PL336937A1 (en) 2000-07-17
WO1998052923A1 (en) 1998-11-26
DK0983246T3 (da) 2003-03-24
AU8434498A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
RS86804A (en) Quinoline and isoquinoline derivatives method for the production thereof and use therof as anti-inflammatory agents
HK1047098A1 (en) Tri-aryl acid derivatives as ppar receptor ligands.
TR200103273T2 (tr) Hemisentetik yöntem ve yeni bileşimler.
MXPA03011681A (es) Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular.
NO20021999D0 (no) Spaltning av intermediater i syntesen av hovedsakelig rent bicalutamid
MY106606A (en) Cycloalkyl-substituted glutaramide antihypertensive agents.
ATE245351T1 (de) Eletrolytische synthese von peressigsäure
IL148932A0 (en) INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
HK1023995A1 (en) Synthesis of acridine derivative multidrug-resistant inhibitors
BG106400A (en) Torsemide polymorphs
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
MY120237A (en) Method for the synthesis of quinoline derivatives
AU4498799A (en) Method of preparing 5- or 8-bromoisoquinoline derivatives
HK1046908A1 (en) Intermediates for the production of naphthyridine-3-carboxylic acid derivatives.
WO2001083423A3 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
MX9704677A (es) Procedimientos novedosos para preparar intermediarios de inhibidores de encefalinasa y enzima de conversion a angiotensina y sus intermediarios.
HUP0203214A3 (en) Process for preparing intermediates applicable for synthesis of hiv protease inhibitor
AP9400608A0 (en) "New nicotinic acid derivative".
WO2002042261A8 (en) PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES
HU9901939D0 (en) Process for producing a-nor-seco-steroide compounds
DE60324776D1 (de) Verfahren zur synthese von pergolid
AU7919700A (en) Method for the production of cyanoacetic acid esters
ATE244217T1 (de) Herstellung von beta-mehtylcarbapenem- zwischenprodukten
FI931938A0 (fi) Mellanprodukter vid framstaellning av 4,5-difluorantranilinsyra
MX9601818A (es) Conversion de 8-cloroquinolinas sustituidas a 8-hidroxiquinolinas sustituidas.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110522